RNA binding proteins in end-organ autoimmune pathology

终末器官自身免疫病理学中的 RNA 结合蛋白

基本信息

项目摘要

IL-17 and Th17 cells are dysregulated in many pathologic auto-inflammatory conditions. Antibody-mediated glomerulonephritis (AGN) occurs when unchecked inflammation triggered by autoimmune Ab complexes that deposit in glomeruli and lead to kidney damage, which occurs in conditions such as Goodpasture disease, ANCA vasculitis, etc. Although the initiators of autoantibody-mediated pathology differ, the terminal events in end organ kidney damage have many common hallmarks, and the fundamental immunology of this process is still not well understood. Accumulating evidence from our groups and others have convincingly demonstrated role for IL-17 in driving pathogenesis of AGN in humans and in mouse models. Excessive autoimmune pathology can be caused by hyper-production of cytokines from T helper cells or by over-exuberant cytokine signaling. Therefore, in principle, molecules that influence IL-17 signal transduction have the potential to be viable targets for therapy in settings where this cytokine is a disease driver. In probing the fundamental mechanisms that mediate IL-17-dependent signaling, we identified two novel RNA binding proteins (RBPs) that contribute significantly to the pathogenesis of AGN in vivo. These RBPs are downstream of IL-17 and their activities in the IL- 17 pathway are interconnected through regulation of CCAAT Enhancer Binding Protein (C/EBP) transcription factors. In turn, C/EBPs mediate IL-17-dependent effectors that promote renal inflammation, including Lipocalin-2, neutrophil-recruiting chemokines, and feed-forward activators of Th17 differentiation such as IL-6. Our central hypothesis is that IL-17 promotes inflammation through post-transcriptional regulation of downstream mRNAs that drive renal pathology in AGN. This proposal will evaluate the molecular mechanisms by which these RBPs act and the specific physiological functions in the setting of AGN.
IL-17和Th 17细胞在许多病理性自身炎性病症中失调。 抗体介导的肾小球肾炎(AGN)发生时,未经检查的炎症触发的 自身免疫抗体复合物,存款在肾小球中并导致肾损伤,发生在 条件,如古德帕斯彻病,ANCA血管炎等。 自身抗体介导的病理学不同,终末器官肾损伤的终末事件有 许多共同的标志,这一过程的基本免疫学仍然不是很好 明白从我们的团队和其他人那里积累的证据已经令人信服地证明了 IL-17在人类和小鼠模型中驱动AGN发病机制的作用。过度 自身免疫病理学可由T辅助细胞过度产生细胞因子或由 过度旺盛的细胞因子信号传导。因此,原则上,影响IL-17信号的分子 转导有可能成为治疗的可行靶点,在这种细胞因子是一种细胞因子的环境中, 疾病司机在探索介导IL-17依赖性信号传导的基本机制时, 我们发现了两种新的RNA结合蛋白(RBP),它们对细胞凋亡有重要作用。 AGN在体内的发病机制。这些RBP是IL-17的下游,并且它们在IL-17中的活性在IL-17中是不稳定的。 17条通路通过调节CCAAT增强子结合蛋白(C/EBP)相互连接 转录因子反过来,C/EBP介导IL-17依赖性效应物,其促进肾功能。 炎症,包括Lipocalin-2、趋化因子和前馈激活剂 Th 17分化,如IL-6。我们的中心假设是IL-17促进炎症 通过下游mRNA的转录后调节,驱动AGN中的肾脏病理。 该提案将评估这些RBP作用的分子机制和特定的 活动星系核的生理功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Partha Sarathi Biswas其他文献

Correction: Genomic prediction and QTL analysis for grain Zn content and yield in Aus-derived rice populations
  • DOI:
    10.1007/s13562-025-00983-8
  • 发表时间:
    2025-04-28
  • 期刊:
  • 影响因子:
    1.500
  • 作者:
    Tapas Kumer Hore;C. H. Balachiranjeevi;Mary Ann Inabangan-Asilo;C. A. Deepak;Alvin D. Palanog;Jose E. Hernandez;Glenn B. Gregorio;Teresita U. Dalisay;Maria Genaleen Q. Diaz;Roberto Fritsche Neto;Md. Abdul Kader;Partha Sarathi Biswas;B. P. Mallikarjuna Swamy
  • 通讯作者:
    B. P. Mallikarjuna Swamy

Partha Sarathi Biswas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Partha Sarathi Biswas', 18)}}的其他基金

RNA binding proteins in end-organ autoimmune pathology
终末器官自身免疫病理学中的 RNA 结合蛋白
  • 批准号:
    10569112
  • 财政年份:
    2022
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of renal protection against disseminated candidiasis
抵抗播散性念珠菌病的肾脏保护机制
  • 批准号:
    10376250
  • 财政年份:
    2021
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of renal protection against disseminated candidiasis
抵抗播散性念珠菌病的肾脏保护机制
  • 批准号:
    10190010
  • 财政年份:
    2021
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
  • 批准号:
    10454893
  • 财政年份:
    2019
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
  • 批准号:
    9815169
  • 财政年份:
    2019
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
  • 批准号:
    10223106
  • 财政年份:
    2019
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
  • 批准号:
    10673766
  • 财政年份:
    2019
  • 资助金额:
    $ 63.32万
  • 项目类别:
Regulation of IL-17 signaling by RNA binding proteins in kidney diseases
RNA 结合蛋白在肾脏疾病中调节 IL-17 信号传导
  • 批准号:
    9762270
  • 财政年份:
    2019
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of IL-17 Mediated Host Defense in the Kidney
IL-17 介导的肾脏宿主防御机制
  • 批准号:
    9023669
  • 财政年份:
    2015
  • 资助金额:
    $ 63.32万
  • 项目类别:
Mechanisms of IL-17 Mediated Host Defense in the Kidney
IL-17 介导的肾脏宿主防御机制
  • 批准号:
    9144776
  • 财政年份:
    2015
  • 资助金额:
    $ 63.32万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 63.32万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 63.32万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 63.32万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.32万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 63.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 63.32万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 63.32万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 63.32万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 63.32万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 63.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了